This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

The
Dow Jones Industrial Average (
^DJI) is trading up 48 points (+0.3%) at 14,748 as of Thursday, May 2, 2013, 9:35 a.m. ET. During this time, 26.5 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 602.9 million. The NYSE advances/declines ratio sits at 1,815 issues advancing vs. 640 declining with 152 unchanged.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be
UnitedHealth Group (NYSE:
UNH), which is sporting a 65-cent gain (+1.1%) bringing the stock to $60.37. This single gain is lifting the Dow Jones Industrial Average by 4.92 points or roughly accounting for 10.3% of the Dow's overall gain. Volume for UnitedHealth Group currently sits at 124,988 shares traded vs. an average daily trading volume of 6.4 million shares.

UnitedHealth Group has a market cap of $61.16 billion and is part of the health care sector and health services industry. Shares are up 10.1% year to date as of Wednesday's close. The stock's dividend yield sits at 1.4%.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company has a P/E ratio of 11.7, below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates UnitedHealth Group as a
buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

Holding back the Dow today is
Coca-Cola (NYSE:
KO), which is lagging the broader Dow index with a 40-cent decline (-0.9%) bringing the stock to $41.82. Volume for Coca-Cola currently sits at two million shares traded vs. an average daily trading volume of 15.3 million shares.

Coca-Cola has a market cap of $188.53 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 16.4% year to date as of Wednesday's close. The stock's dividend yield sits at 2.6%.

The Coca-Cola Company, a beverage company, engages in the manufacture, marketing, and sale of nonalcoholic beverages worldwide. The company primarily offers sparkling beverages and still beverages. The company has a P/E ratio of 21.8, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Coca-Cola as a
buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, expanding profit margins, increase in stock price during the past year and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income.